Show all
LCS
COPD
CAC
Lung Texture
Neuro-CAD
RT-ACS
Research
Modeler
Others
Search

Summary
Lung cancer is a leading cause of preventable deaths if detected early, which can be achieved through lung cancer screening (LCS) programs using low-dose computed tomography (LDCT) of the chest. Due to the strain on healthcare systems, shortages of specialists, and expensive equipment, innovative solutions like artificial intelligence (AI) are needed to support hospitals. AI has shown promising results in the medical field, particularly in lung cancer detection, and has the potential to save lives.
Coreline Soft's LCS+ tool is designed for the analysis of three main lung diseases: lung cancer, COPD, and coronary artery calcification. It works with different types of CT scans and enables the assessment of nodule volume quantification, VDT, and Lung-RADS score. The application of AI in medicine, specifically lung cancer detection, can help alleviate the burden on healthcare systems and improve early detection, ultimately saving lives. More information about the LCS+ tool can be found at https://grand-challenge.org/aiforradiology/product/coreline-soft-aview-lcs/ and https://www.corelinesoft.com/en/lcs/.
See Lung Cancer with an AI
Cancers, 2023
LCS

Summary
This prospective clinical trial aimed to assess the clinical efficacy and safety of endobronchial valve (EBV) therapy in a Korean population with severe emphysema. The study included 43 consecutive patients with complete fissure and no collateral ventilation. The patients showed significant improvements in forced expiratory volume in 1 second (FEV1), 6-minute walk distance, dyspnea scale, and respiratory questionnaire scores 6 months after EBV therapy. Adverse events were observed in 13 patients, including pneumothorax in 10 cases, with one resulting in death due to tension pneumothorax. The presence of tuberculosis scars did not impact target lobe volume reduction or pneumothorax frequency. The study concluded that EBV therapy was both effective and safe in the Korean patient population, comparable to results reported in Western countries. The analysis method employed in the study has been transferred to AVIEW Fissure Completeness by Coreline Soft. The trial was registered at ClinicalTrials.gov under NCT01869205.
Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report.
International Journal of Chronic Obstructive Pulmonary Disease, Jul 2015
COPD